mRNA Technology Has Potential to Cause Microvascular Injury

Additionally, Dr. J. Patrick Whelan, a pediatric rheumatologist specializing in multisystem inflammatory syndrome, submitted a public comment19 to the FDA back in December 2020, in which he expressed concern that mRNA vaccines have “the potential to cause microvascular injury to…

The Favipiravir Page

Favipiravir – Developed by the Dept. of Defense Successful Treatment Strategy of Turkey against Covid-19 Outbreak Dr . Mobeen Sayed explains the mechanism: Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis…

19 January 2021 | Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases

We sought to determine whether immune reactivity occurs between anti-SARS-CoV-2 protein antibodies and human tissue antigens, and whether molecular mimicry between COVID-19 viral proteins and human tissues could be the cause. We applied both human monoclonal anti-SARS-Cov-2 antibodies (spike protein,…

Vaccine-drug interactions

P F D’Arcy PMID: 6383754 DOI: 10.1177/106002808401800904 Review Drug Intell Clin Pharm . 1984 Sep;18(9):697-700.  Abstract Interaction between a vaccine and a drug has been reported only with influenza vaccine and four drugs (aminopyrine, phenytoin sodium, theophylline, and warfarin sodium),…